Patients with active tuberculosis are more likely to be vitamin D deficient than the rest of the population, according to new clinical findings presented at the annual Society for Endocrinology BES meeting in Harrogate, UK. These show that the majority of TB patients have low levels of vitamin D, leading to the possibility that supplementation could reinforce treatment or could help prevent infection.
Researchers at the Central Middlesex Hospital in London examined the prevalence of vitamin D deficiency in an ethnically-diverse population who had active tuberculosis. Out of 158 patients in the study, only 7% had adequate vitamin D levels. It is currently unclear whether these findings represent a contributory factor to infection or whether it is caused by TB, the researchers said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze